⌘K (Command K) to search

Sign in Sign up free

Insider · CIK 0002008556

Walker Karen Marie

Reports to the SEC for 1 company · EMERYVILLE, CA

Transactions

7

Companies

1

Filings

3

CIK

0002008556

Forms 4 and 5

Insider transactions

7 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-12-15	KYTXKyverna Therapeutics, Inc.M Exercise/Conversion	Chief Technology Officer	MExercise/Conversion	+24K sh	$4.83	+$116K	46,634
2025-12-15	KYTXKyverna Therapeutics, Inc.S Sale	Chief Technology Officer	SSale	−24K sh	$12.20	−$293K	22,636
2025-12-15	KYTXKyverna Therapeutics, Inc. · Stock option (right to buy)M Exercise/Conversion	Chief Technology Officer	MExercise/Conversion	−24K sh	—	—	85,865
2025-04-11	KYTXKyverna Therapeutics, Inc.A Award	Chief Technology Officer	AAward	+13K sh	—	—	22,636
2024-06-06	KYTXKyverna Therapeutics, Inc.M Exercise/Conversion	Chief Technology Officer	MExercise/Conversion	+9,636 sh	$4.42	+$42.6K	9,636
2024-06-06	KYTXKyverna Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Technology Officer	MExercise/Conversion	−9,636 sh	—	—	82,648
2024-04-11	KYTXKyverna Therapeutics, Inc. · Stock Option (right to buy)A Award	Chief Technology Officer	AAward	+80K sh	—	—	80,000

Recent filings

3

Accepted (ET)
Dec 174
Walker Karen Marie0001193125-25-323332
SEC(opens sec.gov)
Apr 154
Walker Karen Marie0000950170-25-054342
SEC(opens sec.gov)
Jun 104
Walker Karen Marie0000950170-24-071493
SEC(opens sec.gov)

Companies

1

Kyverna Therapeutics, Inc.Chief Technology OfficerKYTX

Address

C/O KYVERNA THERAPEUTICS, INC. 5980 HORTON ST., STE 550

EMERYVILLE, CA, 94608